Antengene unveils three pipeline programs at AACR 2026 as AnTenGager platform expands beyond UCB deal
Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
Read More Pharma Industry News Lupin secures US FDA tentative approval for generic version of Slynd contraceptive tablets Lupin wins US FDA tentative approval for generic drospirenone contraceptive, targeting a $141M US market. See how this move fits its women’s health strategy. byPallavi MadhirajuNovember 4, 2022